6-(3-cyano-4-pyrrolidin-1-ylphenyl)-4-oxo-1-(2-pyrrolidin-1-yl-1,3-benzoxazol-6-yl)pyridine-3-carboxylic acid
C28H25N5O4 — CID 166541005
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(3-cyano-4-pyrrolidin-1-ylphenyl)-4-oxo-1-(2-pyrrolidin-1-yl-1,3-benzoxazol-6-yl)pyridine-3-carboxylic acid
6-(3-cyano-4-pyrrolidin-1-ylphenyl)-4-oxo-1-(2-pyrrolidin-1-yl-1,3-benzoxazol-6-yl)pyridine-3-carboxylic acid (PubChem CID 166541005) has the molecular formula C28H25N5O4 and a molecular weight of 495.54 g/mol. Its IUPAC name is 6-(3-cyano-4-pyrrolidin-1-ylphenyl)-4-oxo-1-(2-pyrrolidin-1-yl-1,3-benzoxazol-6-yl)pyridine-3-carboxylic acid.
Molecular Properties
| Compound Name | 6-(3-cyano-4-pyrrolidin-1-ylphenyl)-4-oxo-1-(2-pyrrolidin-1-yl-1,3-benzoxazol-6-yl)pyridine-3-carboxylic acid |
|---|---|
| PubChem CID | 166541005 |
| Molecular Formula | C28H25N5O4 |
| Molecular Weight | 495.54 g/mol |
| Exact Mass | 495.19 |
| IUPAC Name | 6-(3-cyano-4-pyrrolidin-1-ylphenyl)-4-oxo-1-(2-pyrrolidin-1-yl-1,3-benzoxazol-6-yl)pyridine-3-carboxylic acid |
| SMILES | N#Cc1cc(-c2cc(=O)c(C(=O)O)cn2-c2ccc3nc(N4CCCC4)oc3c2)ccc1N1CCCC1 |
| InChI | InChI=1S/C28H25N5O4/c29-16-19-13-18(5-8-23(19)31-9-1-2-10-31)24-15-25(34)21(27(35)36)17-33(24)20-6-7-22-26(14-20)37-28(30-22)32-11-3-4-12-32/h5-8,13-15,17H,1-4,9-12H2,(H,35,36) |
| InChIKey | KRJVFFROQZRQFQ-UHFFFAOYSA-N |
| XLogP | 4.42 |
| TPSA | 115.60 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 495.54 |
| LogP ≤ 5 | 4.42 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166541005 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.